-
2
-
-
48949119473
-
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
-
Fillmore CM and Kuperwasser C: Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25, 2008.
-
(2008)
Breast Cancer Res
, vol.10
-
-
Fillmore, C.M.1
Kuperwasser, C.2
-
4
-
-
33947095683
-
CD133, one of the markers of cancer stem cells in Hep-2 cell line
-
Zhou L, Wei X, Cheng L, Tian J and Jiang JJ: CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope 117: 455-460, 2007.
-
(2007)
Laryngoscope
, vol.117
, pp. 455-460
-
-
Zhou, L.1
Wei, X.2
Cheng, L.3
Tian, J.4
Jiang, J.J.5
-
5
-
-
84867756302
-
+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma
-
+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma. Int J Oncol 41: 1570-1576, 2012.
-
(2012)
Int J Oncol
, vol.41
, pp. 1570-1576
-
-
Sharma, B.K.1
Manglik, V.2
O'Connell, M.3
-
6
-
-
79953332194
-
Cancer stem-like cells enriched in panc-1 spheres possess increased migration ability and resistance to gemcitabine
-
Yin T, Wei H, Gou S, et al: Cancer stem-like cells enriched in panc-1 spheres possess increased migration ability and resistance to gemcitabine. Int J Mol Sci 12: 1595-1604, 2011.
-
(2011)
Int J Mol Sci
, vol.12
, pp. 1595-1604
-
-
Yin, T.1
Wei, H.2
Gou, S.3
-
8
-
-
84857657980
-
Current treatment options for metastatic head and neck cancer
-
Price KA and Cohen EE: Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol 13: 35-46, 2012.
-
(2012)
Curr Treat Options Oncol
, vol.13
, pp. 35-46
-
-
Price, K.A.1
Cohen, E.E.2
-
9
-
-
0026093041
-
Pharmacology of Curcuma longa
-
Ammon HP and Wahl MA: Pharmacology of Curcuma longa. Planta Med 57: 1-7, 1991.
-
(1991)
Planta Med
, vol.57
, pp. 1-7
-
-
Ammon, H.P.1
Wahl, M.A.2
-
10
-
-
55949095821
-
Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells
-
Reuter S, Eifes S, Dicato M, Aggarwal BB and Diederich M: Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76: 1340-1351, 2008.
-
(2008)
Biochem Pharmacol
, vol.76
, pp. 1340-1351
-
-
Reuter, S.1
Eifes, S.2
Dicato, M.3
Aggarwal, B.B.4
Diederich, M.5
-
11
-
-
79952025567
-
Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment
-
Teiten MH, Eifes S, Dicato M and Diederich M: Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) 2: 128-162, 2010.
-
(2010)
Toxins (Basel)
, vol.2
, pp. 128-162
-
-
Teiten, M.H.1
Eifes, S.2
Dicato, M.3
Diederich, M.4
-
12
-
-
24644508916
-
Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis
-
Li L, Braiteh FS and Kurzrock R: Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104: 1322-1331, 2005.
-
(2005)
Cancer
, vol.104
, pp. 1322-1331
-
-
Li, L.1
Braiteh, F.S.2
Kurzrock, R.3
-
13
-
-
73549115639
-
Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma
-
Yamano Y, Uzawa K, Saito K, et al: Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma. Int J Cancer 126: 437-449, 2010.
-
(2010)
Int J Cancer
, vol.126
, pp. 437-449
-
-
Yamano, Y.1
Uzawa, K.2
Saito, K.3
-
14
-
-
84862517728
-
Cancer stem cells: Current status and evolving complexities
-
Visvader JE and Lindeman GJ: Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10: 717-728, 2012.
-
(2012)
Cell Stem Cell
, vol.10
, pp. 717-728
-
-
Visvader, J.E.1
Lindeman, G.J.2
-
15
-
-
70349479538
-
+ cells display stem-like features and are spared by cisplatin treatment
-
+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106: 16281-16286, 2009.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 16281-16286
-
-
Bertolini, G.1
Roz, L.2
Perego, P.3
-
18
-
-
0034795256
-
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
-
Zhou S, Schuetz JD, Bunting KD, et al: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028-1034, 2001.
-
(2001)
Nat Med
, vol.7
, pp. 1028-1034
-
-
Zhou, S.1
Schuetz, J.D.2
Bunting, K.D.3
-
19
-
-
71049156626
-
ABCG2: The key to chemoresistance in cancer stem cells?
-
An Y and Ongkeko WM: ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol 5: 1529-1542, 2009.
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 1529-1542
-
-
An, Y.1
Ongkeko, W.M.2
-
20
-
-
25444458009
-
A distinct 'side population' of cells in human tumor cells: Implications for tumor biology and therapy
-
Hirschmann-Jax C, Foster AE, Wulf GG, Goodell MA and Brenner MK: A distinct 'side population' of cells in human tumor cells: implications for tumor biology and therapy. Cell Cycle 4: 203-205, 2005.
-
(2005)
Cell Cycle
, vol.4
, pp. 203-205
-
-
Hirschmann-Jax, C.1
Foster, A.E.2
Wulf, G.G.3
Goodell, M.A.4
Brenner, M.K.5
|